Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 3;16(1):791.
doi: 10.4081/mrm.2021.791. eCollection 2021 Jan 15.

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis

Valeria Giacon  1 , Stefano Sanduzzi Zamparelli  1 , Alessandro Sanduzzi Zamparelli  1   2 , Dario Bruzzese  3 , Marialuisa Bocchino  1
Affiliations

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis

Valeria Giacon et al. Multidiscip Respir Med. .

Abstract

Background: Currently, the prognosis of bronchiectasis is based on different prognostic indicators, like BSI and FACED score, founded on clinical-demographic, functional and radiological criteria. Both scoring systems include the number of lobes involved in bronchiectasis, which represents an adverse prognostic index. Our study aimed to investigate the prognostic role of the clinical-functional parameters and the number of involved lobes ratio in adult bronchiectasis.

Methods: The study was conducted on 52 patients diagnosed with non-cystic fibrosis bronchiectasis (NCFB) between 2015 and 2017 who attended the Pneumology Unit of Monaldi Hospital in Naples, Italy. Correlations between clinical- functional parameters (BMI, smoking history, number of exacerbations in the previous year, spirometry, DLCO, ABG test, and 6MWT) and number of involved lobes were investigated.

Results: At baseline, the number of exacerbations in the previous year had a statistically significant association with the number of involved lobes. Furthermore, at baseline, the radiological criterion was also negatively associated with some functional parameters (FEV1/FVC ratio e FEF25-75%). Statistical significance was lost during the follow up, demonstrating the effectiveness of the therapy.

Conclusions: Imaging extension represents a promising biomarker of disease severity as well as a helpful follow up tool for non-Cystic Fibrosis bronchiectasis (NCFB).

Keywords: Bronchiectasis; HRCT; NCFB; exacerbations; lobe; pulmonary function tests.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J 2015;45:1446-62. - PubMed
    1. European Respiratory Society. Bronchiectasis. Chapter 15. In: European lung white book. European Respiratory Society; 2018. Available from: https://www.erswhitebook.org/chapters/bronchiectasis/
    1. de la Rosa D, Martínez-Garcia MA, Olveira C, Girón R, Máiz L, Prados C. Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization, and chronic obstructive pulmonary disease coexistence. Chron Respir Dis 2016;13:361-71. - PMC - PubMed
    1. Loebinger MR, Wells AU, Hansell DM, Chinyanganya N, Devaraj A, Meister M, Wilson R. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009;34:843-9. - PubMed
    1. Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F. Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med 2020;20:15. - PMC - PubMed

LinkOut - more resources